Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
- Autores
- Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto
- Año de publicación
- 2011
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.
Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina - Materia
-
RENAL PATHOLOGY
PODOCYTOPATHY
LUPUS
ELECTRON MICROSCOPY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/241737
Ver los metadatos del registro completo
id |
CONICETDig_23c4dc0adf1979799099123be2c37561 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/241737 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?Gutiérrez, SilvinaPetiti, Juan Pablode Paul, Ana LuciaTorres, Alicia InesMukdsi, Jorge HumbertoRENAL PATHOLOGYPODOCYTOPATHYLUPUSELECTRON MICROSCOPYhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; ArgentinaSociedad Española de Nefrología Dr Rafael Matesanz2011-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/241737Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-2470211-6995CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.revistanefrologia.com/es-linkresolver-lupus-related-podocytopathy-could-it-be-X0211699512000843info:eu-repo/semantics/altIdentifier/doi/10.3265/Nefrologia.pre2011.Nov.11138info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:19:52Zoai:ri.conicet.gov.ar:11336/241737instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:19:52.392CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
title |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
spellingShingle |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? Gutiérrez, Silvina RENAL PATHOLOGY PODOCYTOPATHY LUPUS ELECTRON MICROSCOPY |
title_short |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
title_full |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
title_fullStr |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
title_full_unstemmed |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
title_sort |
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? |
dc.creator.none.fl_str_mv |
Gutiérrez, Silvina Petiti, Juan Pablo de Paul, Ana Lucia Torres, Alicia Ines Mukdsi, Jorge Humberto |
author |
Gutiérrez, Silvina |
author_facet |
Gutiérrez, Silvina Petiti, Juan Pablo de Paul, Ana Lucia Torres, Alicia Ines Mukdsi, Jorge Humberto |
author_role |
author |
author2 |
Petiti, Juan Pablo de Paul, Ana Lucia Torres, Alicia Ines Mukdsi, Jorge Humberto |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
RENAL PATHOLOGY PODOCYTOPATHY LUPUS ELECTRON MICROSCOPY |
topic |
RENAL PATHOLOGY PODOCYTOPATHY LUPUS ELECTRON MICROSCOPY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis. Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina Fil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina Fil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina Fil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina Fil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina |
description |
The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/241737 Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-247 0211-6995 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/241737 |
identifier_str_mv |
Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-247 0211-6995 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.revistanefrologia.com/es-linkresolver-lupus-related-podocytopathy-could-it-be-X0211699512000843 info:eu-repo/semantics/altIdentifier/doi/10.3265/Nefrologia.pre2011.Nov.11138 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Sociedad Española de Nefrología Dr Rafael Matesanz |
publisher.none.fl_str_mv |
Sociedad Española de Nefrología Dr Rafael Matesanz |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846083347504168960 |
score |
13.22299 |